Spago Nanomedical Interim Report January-June 2024
LUND, SE / ACCESSWIRE / August 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Clinical and non-clinical progress in the Tumorad program...
Pharmaceutical
Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023
CHICAGO, IL / ACCESSWIRE / August 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
BioLogic Summit to Demystify the New AI/ML Paradigm in Biologic Drug Development
CHI's New Event to Support the Evolution of Hybrid Scientists in Biopharma R&D BOSTON, Aug. 20, 2024 /PRNewswire/ -- Biopharmaceutical...
IntegriChain Appoints Experienced High-Growth Finance Executive as CFO
PHILADELPHIA, Aug. 20, 2024 /PRNewswire/ -- IntegriChain, the leading provider of revenue optimization technology and insights for the pharmaceutical industry, today...
Clario publishes third annual ESG Report, reaffirms commitment to ethical AI, workforce investment, and sustainability targets
Clario's third annual ESG report for the calendar year 2023 highlights advancements in responsible artificial intelligence (AI), employee program investments,...
A New Reaction to Enhance Aromatic Ketone Use in Chemical Synthesis
Researchers develop a one pot process to transform aromatic ketones to esters, offering advancements in pharmaceutical synthesis and materials science....
MediLedger Partners With Prisma Health to Help Health System Enhance Pricing Accuracy and Contract Management
SAN FRANCISCO, CA / ACCESSWIRE / August 20, 2024 / The MediLedger network is excited to announce its partnership with...
Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit
CHICAGO, IL / ACCESSWIRE / August 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Gilead Sciences: “One of Best Employers for Women” by Forbes
NORTHAMPTON, MA / ACCESSWIRE / August 20, 2024 / For the third year in a row, Forbes has recognized Gilead...
The CBD Vault Exploring China Distribution and JV Opportunities
SCOTTSDALE, AZ / ACCESSWIRE / August 20, 2024 / The landscape of the CBD industry in China is set to...
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs
Promising results with Telomir-1 Demonstrates Potential in Promoting Life Quality and Longevity in Senior DogsTAMPA, FL / ACCESSWIRE / August...
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical...
Roche responds to WHO’s declaration of a global health emergency due to the ongoing mpox outbreak
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain...
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
CORAL GABLES, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical...
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung
NORWOOD, Mass., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced...
Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension
DUBLIN, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform...
Incyclix Bio Appoints Dr. Andrew Beelen as Vice President of Clinical Development
RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing...
LAVA Reports Second Quarter 2024 Financial Results and Business Update
Continued progress in Phase 1/2a dose escalation for LAVA-1207, including the monotherapy arm, now enrolling in dose level 12, and...
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication
CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals...
Sustainable Agriculture: The Growing Need for Biotech Innovations in the World’s Food Supplies
USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC, Aug. 19, 2024 /PRNewswire/ -- USA News...